HOME >> BIOLOGY >> NEWS
Discovery By Fertility Specialist Offers Promise Of Reducing Multiple BirthsTied To Fertility Treatment

ATLANTA -- Preliminary research by a fertility specialist at the University at Buffalo shows for the first time that a hormone whose role in fertility was thought to be limited to triggering ovulation also can support growth of a developing egg follicle during fertility treatment.

Results of the research were presented here today (March 13, 1998) at the annual meeting of the Society for Gynecological Investigation.

The findings suggest that lutenizing hormone (LH), a hormone present in the second half of the menstrual cycle, may perform the critical task of sustaining the growth of egg follicles until ovulation, said Michael W. Sullivan, M.D., UB assistant professor of gynecology and obstetrics and lead researcher on the study.

They have important implications for women undergoing fertility treatments, Sullivan said, because specialists formerly thought the only way to keep a developing egg growing was to administer follicle stimulating hormone, or FSH, which also causes multiple eggs to mature.

By manipulating LH and FSH, Sullivan said it could be possible to sustain the growth and development of one or two follicles in women undergoing fertility treatment while preventing multiple ovulations and thus decreasing the risk of multiple births.

"Nobody has looked at this before, because it wasn't possible until the development of the recombinant form of the two hormones, which happened very recently," Sullivan said. "The finding is very preliminary, but it is promising."

The results are based on a
'"/>

Contact: Lois Baker
baker@newsb.buffalo.edu
716-645-2626
University at Buffalo
13-Mar-1998


Page: 1 2 3 4

Related biology news :

1. Discovery of new shrimp species adds to unique family
2. Discovery of tiny microbes in ancient Greenland glacier may define limits for life on Earth
3. Discovery in parasite movement may offer insights into malaria
4. Scientists find second way to kill cancer cells: Discovery opens possibilities for new therapies
5. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
6. Discovery helps explain how cells package DNA
7. Discovery offers clues to origin of life
8. Discovery could improve anemia treatment in patients
9. Discovery could lead to better treatment for cryptosporidum infections
10. Discovery of brain disorder gene paves way for genetic test
11. Discovery may be first plant cell surface molecule that halts cell proliferation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® test, ... clinically significant acute bacterial and viral respiratory tract infections by testing the ...
(Date:10/11/2017)... YORBA LINDA, CA (PRWEB) , ... October 11, ... ... adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and ... activation (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
Cached News: